Literature DB >> 23608614

Meta-analysis of cohort studies of baseline prehypertension and risk of coronary heart disease.

Li Shen1, Hong Ma, Mei-Xiang Xiang, Jian-An Wang.   

Abstract

Prehypertension is a common condition, but the extent to which it increases the risk for coronary heart disease (CHD) is unclear. The aim of this study was to determine the association between baseline prehypertension and risk for CHD by performing a meta-analysis of prospective cohort studies. A systematic search of published research was conducted through January 2013, using electronic databases and bibliographies of retrieved reports. Studies were included if they reported multivariate-adjusted relative risks (RRs) and corresponding 95% confidence intervals (CIs) of CHD with respect to prehypertension. A random-effects model was used to combine the study-specific risk estimates. Eighteen studies, consisting of 934,106 participants and 14,952 cases, with a median follow-up period of 8.8 years, were included. Prehypertension was associated with a significantly elevated risk for CHD (RR 1.36, 95% CI 1.22 to 1.53). Eight studies consisting of 12 cohorts further provided risk estimates for low-range prehypertension (120/80 to 129/84 mm Hg) and high-range prehypertension (130/85 to 139/89 mm Hg) separately. The risk for CHD increased significantly in high-range prehypertensive populations (RR 1.53, 95% CI 1.19 to 1.97) but not in low-range prehypertensive populations (RR 1.16, 95% CI 0.96 to 1.42). In conclusion, prehypertension is associated with a significantly increased risk for developing CHD, particularly high-range prehypertension. Further well-designed randomized controlled trials are needed to clarify the efficacy of blood pressure reduction in subjects with prehypertension.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23608614     DOI: 10.1016/j.amjcard.2013.03.023

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  29 in total

1.  Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.

Authors:  Joung Sik Son; Seulggie Choi; Kyuwoong Kim; Sung Min Kim; Daein Choi; Gyeongsil Lee; Su-Min Jeong; Seong Yong Park; Yeon-Yong Kim; Jae-Moon Yun; Sang Min Park
Journal:  JAMA       Date:  2018-11-06       Impact factor: 56.272

2.  Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study.

Authors:  Elena Critselis; Christina Chrysohoou; Natasa Kollia; Ekavi N Georgousopoulou; Dimitrios Tousoulis; Christos Pitsavos; Demosthenes B Panagiotakos
Journal:  J Hum Hypertens       Date:  2019-02-11       Impact factor: 3.012

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

4.  Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

5.  Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  J Am Coll Cardiol       Date:  2017-11-13       Impact factor: 24.094

6.  Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.

Authors:  Ann Marie Navar; Michael J Pencina; Eric D Peterson
Journal:  JAMA Cardiol       Date:  2016-11-01       Impact factor: 14.676

7.  Ambulatory blood pressure response to a bout of HIIT in metabolic syndrome patients.

Authors:  M Ramirez-Jimenez; F Morales-Palomo; J G Pallares; Ricardo Mora-Rodriguez; J F Ortega
Journal:  Eur J Appl Physiol       Date:  2017-05-10       Impact factor: 3.078

Review 8.  KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline.

Authors:  Holly J Kramer; Raymond R Townsend; Karen Griffin; Joseph T Flynn; Daniel E Weiner; Michael V Rocco; Michael J Choi; Matthew R Weir; Tara I Chang; Rajiv Agarwal; Srinivasan Beddhu
Journal:  Am J Kidney Dis       Date:  2019-04       Impact factor: 8.860

9.  The Natural History of Patients With Isolated Metabolic Syndrome.

Authors:  Pratik A Patel; Christopher G Scott; Richard J Rodeheffer; Horng H Chen
Journal:  Mayo Clin Proc       Date:  2016-04-08       Impact factor: 7.616

Review 10.  Nonalcoholic fatty liver disease as a multi-systemic disease.

Authors:  Hakan Fotbolcu; Elçin Zorlu
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.